Whit Mayo
Stock Analyst at Leerink Partners
(4.09)
# 560
Out of 4,711 analysts
199
Total ratings
55.37%
Success rate
10.66%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $7.65 | +4.58% | 2 | Nov 19, 2024 | |
| BK BNY Mellon | Maintains: Equal-Weight | $79 → $81 | $77.62 | +4.35% | 4 | Nov 15, 2024 | |
| RF Regions Financial | Maintains: Equal-Weight | $24 → $28 | $23.77 | +17.80% | 5 | Nov 15, 2024 | |
| PNC PNC Financial | Maintains: Overweight | $215 → $235 | $192.76 | +21.91% | 5 | Nov 15, 2024 | |
| FITB Fifth Third Bancorp | Maintains: Overweight | $52 → $54 | $42.93 | +25.79% | 4 | Nov 15, 2024 | |
| BAC Bank of America | Maintains: Overweight | $52 → $56 | $44.17 | +26.78% | 4 | Nov 15, 2024 | |
| MS Morgan Stanley | Upgrades: Equal-Weight | $107 → $142 | $123.44 | +15.04% | 5 | Nov 15, 2024 | |
| ARDT Ardent Health Partners | Maintains: Outperform | $23 → $25 | $16.01 | +56.15% | 2 | Nov 12, 2024 | |
| AHCO AdaptHealth | Maintains: Buy | $13 → $12 | $10.28 | +16.73% | 10 | Nov 6, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $247.10 | +1.17% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $94.45 | +5.88% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $5 | $5.35 | -6.54% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $17.27 | -13.14% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $45 → $52 | $61.16 | -14.98% | 2 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $55 | $69.19 | -20.51% | 3 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $500.13 | +11.97% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $180.11 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $50 → $38 | $53.67 | -29.20% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $566.10 | -31.11% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $98.20 | -1.22% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $189.48 | -18.20% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $20 | $17.09 | +17.03% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $276.92 | +20.97% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $580 | $365.96 | +58.49% | 3 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $84.47 | +0.63% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $303.62 | -5.80% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $21.22 | +88.50% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $20.07 | +94.32% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $3.23 | -53.56% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $1.97 | +1,422.84% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $14.09 | +13.56% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $129.46 | -57.52% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $37.90 | +171.77% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $83.28 | +110.13% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $10.61 | +79.08% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.16 | +26.58% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $228.61 | -11.20% | 2 | May 1, 2018 |
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $7.65
Upside: +4.58%
BNY Mellon
Nov 15, 2024
Maintains: Equal-Weight
Price Target: $79 → $81
Current: $77.62
Upside: +4.35%
Regions Financial
Nov 15, 2024
Maintains: Equal-Weight
Price Target: $24 → $28
Current: $23.77
Upside: +17.80%
PNC Financial
Nov 15, 2024
Maintains: Overweight
Price Target: $215 → $235
Current: $192.76
Upside: +21.91%
Fifth Third Bancorp
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $42.93
Upside: +25.79%
Bank of America
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $56
Current: $44.17
Upside: +26.78%
Morgan Stanley
Nov 15, 2024
Upgrades: Equal-Weight
Price Target: $107 → $142
Current: $123.44
Upside: +15.04%
Ardent Health Partners
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $16.01
Upside: +56.15%
AdaptHealth
Nov 6, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $10.28
Upside: +16.73%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $247.10
Upside: +1.17%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $94.45
Upside: +5.88%
May 14, 2024
Downgrades: Market Perform
Price Target: $5
Current: $5.35
Upside: -6.54%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $17.27
Upside: -13.14%
Dec 14, 2023
Maintains: Underweight
Price Target: $45 → $52
Current: $61.16
Upside: -14.98%
Aug 23, 2023
Maintains: Overweight
Price Target: $60 → $55
Current: $69.19
Upside: -20.51%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $500.13
Upside: +11.97%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $180.11
Upside: -
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $50 → $38
Current: $53.67
Upside: -29.20%
Apr 3, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $566.10
Upside: -31.11%
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $98.20
Upside: -1.22%
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $189.48
Upside: -18.20%
Apr 3, 2023
Maintains: Overweight
Price Target: $21 → $20
Current: $17.09
Upside: +17.03%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $276.92
Upside: +20.97%
Jan 26, 2023
Reiterates: Outperform
Price Target: $580
Current: $365.96
Upside: +58.49%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $84.47
Upside: +0.63%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $303.62
Upside: -5.80%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $21.22
Upside: +88.50%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $20.07
Upside: +94.32%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $3.23
Upside: -53.56%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $1.97
Upside: +1,422.84%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $14.09
Upside: +13.56%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $129.46
Upside: -57.52%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $37.90
Upside: +171.77%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $83.28
Upside: +110.13%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $10.61
Upside: +79.08%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.16
Upside: +26.58%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $228.61
Upside: -11.20%